New Strategies for Treatment of KRAS Mutant Metastatic Colorectal Cancer

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-09-2029
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

KRAS Mutant Allele-Specific Imbalance (MASI) Assessment in Routine Samples of Patients With Metastatic Colorectal Cancer

Journal of Clinical Pathology
MedicineForensic MedicinePathology
2015English

Safety and Efficacy of the Addition of Simvastatin to Cetuximab in Previously Treated KRAS Mutant Metastatic Colorectal Cancer Patients

Investigational New Drugs
OncologyPharmacology
2015English

Rechallenge Therapy and Treatment Holiday: Different Strategies in Management of Metastatic Colorectal Cancer

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2013English

FOLFIRI Plus Panitumumab in the Treatment of Wild-Type KRAS and Wild-Type NRAS Metastatic Colorectal Cancer

World Journal of Surgical Oncology
SurgeryOncology
2018English

A Systematic Review of Treatment Guidelines for Metastatic Colorectal Cancer

Colorectal Disease
Gastroenterology
2012English

New Therapeutic Agents for Metastatic Colorectal Cancer: Literature Review

Colorectal Oncology
2018English

Finding a New Prognostic Biomarker for Metastatic Colorectal Cancer

Journal of the Korean Society of Coloproctology
2012English

Advances in the Treatment of Metastatic Colorectal Cancer

Disease-a-Month
Medicine
2010English

KRAS Mutation Analysis of Single Circulating Tumor Cells From Patients With Metastatic Colorectal Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy